210 related articles for article (PubMed ID: 38259296)
1. Efficacies and ADME properties of redox active methylene blue and phenoxazine analogues for use in new antimalarial triple drug combinations with amino-artemisinins.
Watson DJ; Laing L; Petzer JP; Wong HN; Parkinson CJ; Wiesner L; Haynes RK
Front Pharmacol; 2023; 14():1308400. PubMed ID: 38259296
[TBL] [Abstract][Full Text] [Related]
2. Antimalarial and antitumour activities of the steroidal quinone-methide celastrol and its combinations with artemiside, artemisone and methylene blue.
Ng JPL; Han Y; Yang LJ; Birkholtz LM; Coertzen D; Wong HN; Haynes RK; Coghi P; Wong VKW
Front Pharmacol; 2022; 13():988748. PubMed ID: 36120293
[TBL] [Abstract][Full Text] [Related]
3. The Artemiside-Artemisox-Artemisone-M1 Tetrad: Efficacies against Blood Stage
Gibhard L; Coertzen D; Reader J; van der Watt ME; Birkholtz LM; Wong HN; Batty KT; Haynes RK; Wiesner L
Pharmaceutics; 2021 Dec; 13(12):. PubMed ID: 34959347
[TBL] [Abstract][Full Text] [Related]
4. Toward New Transmission-Blocking Combination Therapies: Pharmacokinetics of 10-Amino-Artemisinins and 11-Aza-Artemisinin and Comparison with Dihydroartemisinin and Artemether.
Watson DJ; Laing L; Gibhard L; Wong HN; Haynes RK; Wiesner L
Antimicrob Agents Chemother; 2021 Jul; 65(8):e0099021. PubMed ID: 34097488
[TBL] [Abstract][Full Text] [Related]
5. Optimal 10-Aminoartemisinins With Potent Transmission-Blocking Capabilities for New Artemisinin Combination Therapies-Activities Against Blood Stage
Wong HN; Padín-Irizarry V; van der Watt ME; Reader J; Liebenberg W; Wiesner L; Smith P; Eribez K; Winzeler EA; Kyle DE; Birkholtz LM; Coertzen D; Haynes RK
Front Chem; 2019; 7():901. PubMed ID: 31998692
[TBL] [Abstract][Full Text] [Related]
6. Artemisone and Artemiside Are Potent Panreactive Antimalarial Agents That Also Synergize Redox Imbalance in Plasmodium falciparum Transmissible Gametocyte Stages.
Coertzen D; Reader J; van der Watt M; Nondaba SH; Gibhard L; Wiesner L; Smith P; D'Alessandro S; Taramelli D; Wong HN; du Preez JL; Wu RWK; Birkholtz LM; Haynes RK
Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29866868
[TBL] [Abstract][Full Text] [Related]
7. Antimalarial efficacy and drug interactions of the novel semi-synthetic endoperoxide artemisone in vitro and in vivo.
Vivas L; Rattray L; Stewart LB; Robinson BL; Fugmann B; Haynes RK; Peters W; Croft SL
J Antimicrob Chemother; 2007 Apr; 59(4):658-65. PubMed ID: 17337512
[TBL] [Abstract][Full Text] [Related]
8. Proteomic characterization of Toxoplasma gondii ME49 derived strains resistant to the artemisinin derivatives artemiside and artemisone implies potential mode of action independent of ROS formation.
Müller J; Schlange C; Heller M; Uldry AC; Braga-Lagache S; Haynes RK; Hemphill A
Int J Parasitol Drugs Drug Resist; 2023 Apr; 21():1-12. PubMed ID: 36512904
[TBL] [Abstract][Full Text] [Related]
9. Considerations on the mechanism of action of artemisinin antimalarials: part 1--the 'carbon radical' and 'heme' hypotheses.
Haynes RK; Cheu KW; N'Da D; Coghi P; Monti D
Infect Disord Drug Targets; 2013 Aug; 13(4):217-77. PubMed ID: 24304352
[TBL] [Abstract][Full Text] [Related]
10. Ex vivo activity of endoperoxide antimalarials, including artemisone and arterolane, against multidrug-resistant Plasmodium falciparum isolates from Cambodia.
Lanteri CA; Chaorattanakawee S; Lon C; Saunders DL; Rutvisuttinunt W; Yingyuen K; Bathurst I; Ding XC; Tyner SD
Antimicrob Agents Chemother; 2014 Oct; 58(10):5831-40. PubMed ID: 25049252
[TBL] [Abstract][Full Text] [Related]
11. In vitro assessment of methylene blue on chloroquine-sensitive and -resistant Plasmodium falciparum strains reveals synergistic action with artemisinins.
Akoachere M; Buchholz K; Fischer E; Burhenne J; Haefeli WE; Schirmer RH; Becker K
Antimicrob Agents Chemother; 2005 Nov; 49(11):4592-7. PubMed ID: 16251300
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and
Anh CX; Chavchich M; Birrell GW; Van Breda K; Travers T; Rowcliffe K; Lord AR; Shanks GD; Edstein MD
Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31907186
[TBL] [Abstract][Full Text] [Related]
13. First assessment in humans of the safety, tolerability, pharmacokinetics, and ex vivo pharmacodynamic antimalarial activity of the new artemisinin derivative artemisone.
Nagelschmitz J; Voith B; Wensing G; Roemer A; Fugmann B; Haynes RK; Kotecka BM; Rieckmann KH; Edstein MD
Antimicrob Agents Chemother; 2008 Sep; 52(9):3085-91. PubMed ID: 18559649
[TBL] [Abstract][Full Text] [Related]
14. Characterization of Novel Antimalarial Compound ACT-451840: Preclinical Assessment of Activity and Dose-Efficacy Modeling.
Le Bihan A; de Kanter R; Angulo-Barturen I; Binkert C; Boss C; Brun R; Brunner R; Buchmann S; Burrows J; Dechering KJ; Delves M; Ewerling S; Ferrer S; Fischli C; Gamo-Benito FJ; Gnädig NF; Heidmann B; Jiménez-Díaz MB; Leroy D; Martínez MS; Meyer S; Moehrle JJ; Ng CL; Noviyanti R; Ruecker A; Sanz LM; Sauerwein RW; Scheurer C; Schleiferboeck S; Sinden R; Snyder C; Straimer J; Wirjanata G; Marfurt J; Price RN; Weller T; Fischli W; Fidock DA; Clozel M; Wittlin S
PLoS Med; 2016 Oct; 13(10):e1002138. PubMed ID: 27701420
[TBL] [Abstract][Full Text] [Related]
15. Activity of Ivermectin and Its Metabolites against Asexual Blood Stage Plasmodium falciparum and Its Interactions with Antimalarial Drugs.
Yipsirimetee A; Tipthara P; Hanboonkunupakarn B; Tripura R; Lek D; Kümpornsin K; Lee MCS; Sattabongkot J; Dondorp AM; White NJ; Kobylinski KC; Tarning J; Chotivanich K
Antimicrob Agents Chemother; 2023 Jul; 67(7):e0173022. PubMed ID: 37338381
[TBL] [Abstract][Full Text] [Related]
16. Comparative ex vivo activity of novel endoperoxides in multidrug-resistant plasmodium falciparum and P. vivax.
Marfurt J; Chalfein F; Prayoga P; Wabiser F; Wirjanata G; Sebayang B; Piera KA; Wittlin S; Haynes RK; Möhrle JJ; Anstey NM; Kenangalem E; Price RN
Antimicrob Agents Chemother; 2012 Oct; 56(10):5258-63. PubMed ID: 22850522
[TBL] [Abstract][Full Text] [Related]
17. Artemisone effective against murine cerebral malaria.
Waknine-Grinberg JH; Hunt N; Bentura-Marciano A; McQuillan JA; Chan HW; Chan WC; Barenholz Y; Haynes RK; Golenser J
Malar J; 2010 Aug; 9():227. PubMed ID: 20691118
[TBL] [Abstract][Full Text] [Related]
18. Absorption of the novel artemisinin derivatives artemisone and artemiside: potential application of Pheroid™ technology.
Steyn JD; Wiesner L; du Plessis LH; Grobler AF; Smith PJ; Chan WC; Haynes RK; Kotzé AF
Int J Pharm; 2011 Jul; 414(1-2):260-6. PubMed ID: 21596127
[TBL] [Abstract][Full Text] [Related]
19. Design, economical synthesis and antiplasmodial evaluation of vanillin derived allylated chalcones and their marked synergism with artemisinin against chloroquine resistant strains of Plasmodium falciparum.
Sharma N; Mohanakrishnan D; Sharma UK; Kumar R; Richa ; Sinha AK; Sahal D
Eur J Med Chem; 2014 May; 79():350-68. PubMed ID: 24747290
[TBL] [Abstract][Full Text] [Related]
20. Methylene Homologues of Artemisone: An Unexpected Structure-Activity Relationship and a Possible Implication for the Design of C10-Substituted Artemisinins.
Wu Y; Wu RW; Cheu KW; Williams ID; Krishna S; Slavic K; Gravett AM; Liu WM; Wong HN; Haynes RK
ChemMedChem; 2016 Jul; 11(13):1469-79. PubMed ID: 27273875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
